TCG Lifesciences Pvt. Limited (formerly “Chembiotek Research International”) is a leading global Contract Research and Manufacturing Services (CRAMS) company in the area of drug discovery and development. We started our operations in 2001 in Kolkata, India and currently have our presence in the United States, Europe, and Japan.
We have a strong talent pool of 850+ qualified and trained scientists and close to 200 PhDs, drawn from the best domestic and international institutes and industry. Our services span chemistry, in vitro and in vivo pharmacology, analytical development and validation, and specialty chemicals. We offer specific/functional solutions to integrated projects across multiple therapeutic areas with specific focus on Inflammation & Pain, Infectious Diseases, Central Nervous System and Oncology. Our research infrastructure includes world-class chemistry and biology laboratories, animal facility, electrophysiology laboratory, BSL 2 laboratory, and cGMP facilities at our R&D centers.
Partner with global pharma and biotechnology companies and collaboratively discover new molecules to address the unmet medical needs. Collaborate with bio-medical researchers, research institutions and academia to accelerate generation of knowledge and leverage innovation and technology platforms.
We are a part of ‘The Chatterjee Group’ (TCG), a global investment conglomerate headquartered in New York with strategic investments of over USD 1 Billion. The group is established by Dr. Purnendu Chatterjee. TCG is internationally known for generating significant capital appreciation through long term strategic investments, both in the private and public sectors. Dr. Chattejee has made several strategic investments in India, particularly in knowledge intensive industries, such as Information Technology, IT enabled services, Life Sciences, Real Estate and Petrochemicals amongst others.